Literature DB >> 11431098

Trk receptor tyrosine kinases: a bridge between cancer and neural development.

A Nakagawara1.   

Abstract

The proto-oncogene Trks encode the high-affinity receptor tyrosine kinases for neurotrophins of a nerve growth factor (NGF) family. The Trk signals spatiotemporally regulate neural development and maintenance of neural network. However, Trk was originally cloned as an oncogene fused with the tropomyosin gene in the extracellular domain. Accumulating evidence has demonstrated that the rearranged Trk oncogene is often observed in non-neuronal neoplasms such as colon and papillary thyroid cancers, while the signals through the receptors encoded by the proto-oncogene Trks regulate growth, differentiation and apoptosis of the tumors with neuronal origin such as neuroblastoma and medulloblastoma. The intracellular Trk signaling pathway is also different depending on the Trk family receptors, cell types and the grade of transformation. Furthermore, developmentally programmed cell death of neuron, which is largely regulated by neurotrophin signaling, is at least in part controlled by tumor suppressors p53 and p73 as well as their antagonist DeltaNp73. Thus, the Trks and their downstream signaling function in both ontogenesis and oncogenesis. In this short review, the dynamic role of the Trk family receptors signaling in neural development, neurogenic tumors and other cancers will be discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431098     DOI: 10.1016/s0304-3835(01)00530-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  119 in total

1.  TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.

Authors:  Jamie L Croucher; Radhika Iyer; Nanxin Li; Valentina Molteni; Jon Loren; W Perry Gordon; Tove Tuntland; Bo Liu; Garrett M Brodeur
Journal:  Cancer Chemother Pharmacol       Date:  2014-11-14       Impact factor: 3.333

Review 2.  Emerging treatments and gene expression profiling in high-risk medulloblastoma.

Authors:  Iacopo Sardi; Duccio Cavalieri; Maura Massimino
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 3.  Cardiovascular actions of neurotrophins.

Authors:  Andrea Caporali; Costanza Emanueli
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 4.  Emerging Gene Fusion Drivers in Primary and Metastatic Central Nervous System Malignancies: A Review of Available Evidence for Systemic Targeted Therapies.

Authors:  Priscilla K Brastianos; Franziska Maria Ippen; Umbreen Hafeez; Hui K Gan
Journal:  Oncologist       Date:  2018-04-27

5.  The alternative TrkAIII splice variant targets the centrosome and promotes genetic instability.

Authors:  Antonietta Rosella Farina; Antonella Tacconelli; Lucia Cappabianca; Gesilia Cea; Sonia Panella; Antonella Chioda; Alessandra Romanelli; Carlo Pedone; Alberto Gulino; Andrew Reay Mackay
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

6.  BDNF/TrkB Signaling as a Potential Novel Target in Pediatric Brain Tumors: Anticancer Activity of Selective TrkB Inhibition in Medulloblastoma Cells.

Authors:  Amanda Thomaz; Mariane Jaeger; Marienela Buendia; Victorio Bambini-Junior; Lauro José Gregianin; Algemir Lunardi Brunetto; André T Brunetto; Caroline Brunetto de Farias; Rafael Roesler
Journal:  J Mol Neurosci       Date:  2015-11-27       Impact factor: 3.444

7.  Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma.

Authors:  T M Wright; A R Brannon; J D Gordan; A J Mikels; C Mitchell; S Chen; I Espinosa; M van de Rijn; R Pruthi; E Wallen; L Edwards; R Nusse; W K Rathmell
Journal:  Oncogene       Date:  2009-05-18       Impact factor: 9.867

8.  c.1810C>T polymorphism of NTRK1 gene is associated with reduced survival in neuroblastoma patients.

Authors:  Beata S Lipska; Elzbieta Drozynska; Paola Scaruffi; Gian Paolo Tonini; Ewa Izycka-Swieszewska; Szymon Zietkiewicz; Anna Balcerska; Danuta Perek; Alicja Chybicka; Wojciech Biernat; Janusz Limon
Journal:  BMC Cancer       Date:  2009-12-13       Impact factor: 4.430

Review 9.  Neuronal apoptosis by prolyl hydroxylation: implication in nervous system tumours and the Warburg conundrum.

Authors:  Susanne Schlisio
Journal:  J Cell Mol Med       Date:  2009-08-19       Impact factor: 5.310

10.  Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE.

Authors:  Kim M Lonergan; Raj Chari; Bradley P Coe; Ian M Wilson; Ming-Sound Tsao; Raymond T Ng; Calum Macaulay; Stephen Lam; Wan L Lam
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.